Robert W. Schrepfer is VP at ANI PHARMACEUTICALS INC (ANIP). They have made 7 open-market trades across 1 company since 2016, most recently 2021-03-29.
CIK 0001023024
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 7 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| ANIP | 87,477 | $6.3M |
Shares reported on the most recent Form 4, priced at the 2021-03-29 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| ANIP | SELL | 2019-05-13 | 2019-05-13 | $71.13 | $343K | -3.0% | +0.4% | +1.1% |
| ANIP | SELL | 2019-03-13 | 2019-03-14 | $64.43 | $300K | +6.4% | +7.1% | +10.9% |
| ANIP | SELL | 2019-03-12 | 2019-03-14 | $64.44 | $760K | +6.4% | +7.1% | +10.9% |
| ANIP | SELL | 2019-03-12 | 2019-03-14 | $64.45 | $461K | +6.4% | +7.1% | +10.9% |
| ANIP | SELL | 2018-03-01 | 2018-03-05 | $61.66 | $2.8M | -7.0% | -7.7% | -1.2% |
| ANIP | SELL | 2016-08-08 | 2016-08-09 | $67.06 | $838K | -2.9% | -11.8% | -24.5% |
| ANIP | SELL | 2016-08-08 | 2016-08-09 | $67.06 | $838K | -2.9% | -11.8% | -24.5% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.